These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4259526)

  • 1. Toward an understanding of the pathophysiology of Huntington's chorea.
    Klawans HL; Ilahi MM; Ringel SP
    Confin Neurol; 1971; 33(5):297-303. PubMed ID: 4259526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Huntington chorea. Review of the most recent aspects of research].
    Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
    Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
    Bernheimer H; Birkmayer W; Hornykiewicz O; Jellinger K; Seitelberger F
    J Neurol Sci; 1973 Dec; 20(4):415-55. PubMed ID: 4272516
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemistry of Huntington's chorea.
    Lancet; 1980 May; 1(8178):1119-20. PubMed ID: 6103447
    [No Abstract]   [Full Text] [Related]  

  • 5. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.
    Jamwal S; Kumar P
    Curr Neuropharmacol; 2019; 17(2):165-175. PubMed ID: 29512464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of chorea and bradykinesia in Huntington's disease.
    Berardelli A; Noth J; Thompson PD; Bollen EL; Currà A; Deuschl G; van Dijk JG; Töpper R; Schwarz M; Roos RA
    Mov Disord; 1999 May; 14(3):398-403. PubMed ID: 10348461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in understanding Huntington's chorea.
    Barbeau A
    Can J Neurol Sci; 1975 May; 2(2):81-5. PubMed ID: 124199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pallidum in genesis of some choreic movements.
    SPIEGEL EA; WYCIS HT
    Neurology; 1953 Apr; 3(4):261-6. PubMed ID: 13054853
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Rigidity in Huntington's chorea.
    Bird ED; Iversen LL
    Lancet; 1974 Mar; 1(7855):463. PubMed ID: 4131474
    [No Abstract]   [Full Text] [Related]  

  • 11. Huntington's disease.
    Haddad MS; Cummings JL
    Psychiatr Clin North Am; 1997 Dec; 20(4):791-807. PubMed ID: 9443350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chorea.
    Klawans HL
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):536-40. PubMed ID: 2445458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hard target: understanding dopaminergic neurotransmission.
    Nestler EJ
    Cell; 1994 Dec; 79(6):923-6. PubMed ID: 8001139
    [No Abstract]   [Full Text] [Related]  

  • 14. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.
    Coyle JT; Schwarcz R
    Nature; 1976 Sep; 263(5574):244-6. PubMed ID: 8731
    [No Abstract]   [Full Text] [Related]  

  • 15. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Pathogenesis of Huntington's chorea, Pick's disease, and paralysis agitans.
    van Wolferen WJ; Bruyn GW; Teepen JL
    Lancet; 1974 Jun; 1(7866):1112. PubMed ID: 4135274
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease.
    Martinez-Mir MI; Probst A; Palacios JM
    Neuroscience; 1991; 42(3):697-706. PubMed ID: 1835521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.
    Miller S; Hill Della Puppa G; Reidling J; Marcora E; Thompson LM; Treanor J
    J Huntingtons Dis; 2014; 3(4):333-41. PubMed ID: 25575954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
    Watson DL; Carpenter CL; Marks SS; Greenberg DA
    Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical mechanisms and management of choreiform movement disorders.
    de Silva L
    Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.